-+ 0.00%
-+ 0.00%
-+ 0.00%

MEDIPHARM LABS CORP - PHASE II LIBBY TRIAL TREATMENT BENEFITS SUSTAINED THROUGHOUT 12-WEEK DOUBLE-BLIND PERIOD

路透·07/14/2026 12:35:30

登錄查看新聞詳情